[ntuh hsin-chu branch][department of pharmacy][2013.01.23 seminar][ivig in autoimmune and...
TRANSCRIPT
Intravenous Immune Globulin in Autoimmune and Inflammatory Disease
NEW ENGLAND JOURNAL OF MEDICINEMECHANISMS OF DISEASE
Speaker: Pharmacist Ting-wei WuDepartment of Pharmacy
Jan. 23rd, 2013
1
Outline
What is IVIG?FDA-approved indicationAdditional approved indication with criteriaNational Health Insurance (in Taiwan) Criteria for IVIGHow do Immunoglobulins been produced?How does Immunoglobulin looks like?How does Immunoglobulin work?IVIG for Primary ImmunodeficiencyIVIG for Bone Marrow TransplantationIVIG for Kawasaki’s DiseaseIVIG for Idiopathic Thrombocytopenic PurpuraIVIG for Guillain–Barré SyndromeIVIG preparation in our hospitalSummaryReference
2
What is IVIG?
IVIG is stands for Intravenous Immune Globulin.
IVIG is prepared from plasma pooled from thousands of healthy donors.
More than a dozen preparations suitable for intravenous administration have been approved by the FDA for the treatment of primary immunodeficiency disease.
3
FDA-approved indication
Primary immunodeficiency disease
Chronic lymphocytic leukemia
Pediatric HIV infection
Kawasaki’s disease
Allogeneic bone marrow transplantation
Chronic inflammatory demyelinating polyneuropathy
Multifocal motor neuropathy
4
Additional approved indication with criteria
Neuromuscular disorders
Guillain–Barré syndrome
Myasthenia gravis
Hematologic disorders
Autoimmune hemolytic anemia
Neonatal alloimmune thrombocytopenia
Dermatologic disorders
Ref: N Engl J Med 2012;367:2015-25.DOI: 10.1056/NEJMra10094335
National Health Insurance (in Taiwan)Criteria for IVIG
1.先天或後天性免疫球蛋白低下症併發嚴重感染時(須附六個月內免疫球蛋白檢查報告)
2.免疫血小板缺乏性紫斑症(ITP)病例經傳統治療無效且血小板嚴重低下(< 20,000/cumm)合併有嚴重出血危及生命者。
3.免疫血小板缺乏性紫斑(ITP)病例合併血小板嚴重低下(< 20,000/cumm)或合併有嚴重出血而又必須接受緊急手術治療者。
4.先天性免疫不全症之預防性使用,但需有醫學中心之診斷証明。
5.川崎病合乎美國疾病管制中心所訂之診斷標準,限由區域醫院(含)以上教學醫院實施,並填寫「全民健康保險使用Intravenous Immune Globulin (IVIG) 治療川崎病」申請表併當月份醫療費用申報。
6.因感染誘發過度免疫機轉反應,而致維生重要器官衰竭,有危及生命之慮者,限由區域醫院(含)以上有加護病房⼄乙等級以上之教學醫院實施。(93/2/1)
7. 腸病毒感染嚴重患者,且符合行政院衛生署疾病管制局於97年1月修訂之『腸病毒感染嚴重患者靜脈注射免疫球蛋白之適應症』。(97/5/9)
Ref: Bureau of National Health Iinsurance, Department of Health, Executive Yuan6
How do Immunoglobulins been produced?Ref: Vander's Human Physiology: The Mechanisms of Body Function, 11e, FIGURE 18-14
7
How does Immunoglobulin look like?Ref: N Engl J Med 2012;367:2015-25.DOI: 10.1056/NEJMra1009433
8
How does Immunoglobulin work?Ref: N Engl J Med 2012;367:2015-25.DOI: 10.1056/NEJMra1009433
9
How does Immunoglobulin work?Ref: N Engl J Med 2012;367:2015-25.DOI: 10.1056/NEJMra1009433
10
IVIG for Primary Immunodeficiency
Dosage of IVIG for Primary immunodeficiency disease:
0.2-0.6g /kg each month
ReF: National Taiwan University Hospital Hsin-Chu Branch Formulary, 101 1st ED, p174
11
IVIG for Bone Marrow Transplantation
Dosage of IVIG for allogeneic bone marrow transplantation:
Initial dose: 0.5g /kg /week
ReF: National Taiwan University Hospital Hsin-Chu Branch Formulary, 101 1st ED, p174
12
IVIG for Kawasaki’s disease
Underlying pathophysiological characteristics of the disease remain to be clearly defined.
The anti-inflammatory potential of IVIG in patients with Kawasaki’s disease has been well described.
After a single intravenous infusion of immune globulin, fever often abates, with concomitant reductions in several inflammatory markers.
Ref: N Engl J Med 2012;367:2015-25.DOI: 10.1056/NEJMra1009433
13
IVIG for Kawasaki’s disease
Decreases in the production of pro-inflammatory cytokines (e.g., tumor necrosis factor α [TNF-α], interleukin-1α, and interleukin-6)
Down-regulation of adhesion molecule and chemokine and chemokine-receptor expression
Neutralization of super-antigens
Ref: N Engl J Med 2012;367:2015-25.DOI: 10.1056/NEJMra1009433
14
IVIG for Kawasaki disease
Dosage of IVIG for Kawasaki’s disease:
1.6-2g /kg in two to five days
2g /kg for single dose
ReF: National Taiwan University Hospital Hsin-Chu Branch Formulary, 101 1st ED, p174
15
IVIG for ITP
ITP stands for idiopathic thrombocytopenic purpura.
ITP is primarily a disease of increased peripheral platelet destruction.
Most patients have immunoglobulin G autoantibodies to specific membrane glycoproteins on the platelet surface.
16
IVIG for ITP
Dosage of IVIG for ITP:
2g /kg in two to five days
ReF: National Taiwan University Hospital Hsin-Chu Branch Formulary, 101 1st ED, p174
17
IVIG for GBS
GBS stands for Guillain–Barré Syndrome which is a post-infectious, immune-mediated disease.
The pathophysiologic mechanism of GBS can be typified by C jejuni infections.
Immune responses against lipopolysaccharide antigens in the capsule of C jejuni.
Antibodies cross-react with ganglioside GM1 in myelin, resulting in the immunologic damage to the peripheral nervous system.
18
Ref: Vander's Human Physiology: The Mechanisms of Body Function, 11e, FIGURE 6-2
19
IVIG for GBS
Dosage of IVIG for Guillain–Barré syndrome:
2g /kg in five days
20
IVIG preparation in our hospital
Human Immunoglobulin (TBSF) injection (6% 3g/50mL/btl)
Cost: $6750 NTD/btl
How supply:IVIG dilutes with 50mL D5W or NSIntravenous infusion; infusion rate:1 mL/min for first 15 min3-4 mL/min for max speed
21
SummaryThe use of IVIG has been firmly established for the treatment of a wide variety of autoimmune and inflammatory diseases, either as adjunctive therapy or as first-line therapy in some conditions, such as Kawasaki’s disease.
Results in animal models have not been entirely consistent and easy to translate to human disease. Double-blind, placebo-controlled trials remain essential to establish the efficacy of this intervention a variety of disease states.
IVIG therapy, especially at doses of 2 g per kilogram per month, is expensive, and with expanding use there are concerns about present and future supplies, especially if the donor pool decreases or is limited by safety issues and increased pathogen screening of donors of the source plasma.
Attempts to bioengineer a protein with immunomodulatory activities similar to those of native IgG should be a priority if we are to sustain this approach to disease modification.
The successes with IVIG witnessed over the past few decades are just the beginning. Now the real work needs to begin.
22
Reference:
N Engl J Med 2012;367:2015-25.DOI: 10.1056/NEJMra1009433
Vander's Human Physiology: The Mechanisms of Body Function, 11e; ISBN 978-986-157-640-4
National Taiwan University Hospital Hsin-Chu Branch Formulary, 101 1st ED
23
Thanks For Your Attention.
24